Article Information
History
- July 31, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Filipe B Rodrigues, MD1,
- Gail Owen, PhD1,
- Swati Sathe, MD2,
- Elena Pak, MS2,
- Dipinder Kaur2,
- Anka G Ehrhardt, PhD2,
- Sherry Lifer, MS2,
- Jenny Townhill, PhD3,
- Katarzyna Schubert, PhD1,
- Blair R Leavitt, MD4,
- Mark Guttman, MD5,
- Jee Bang, MD6,
- Jan Lewerenz, MD7,
- Jamie Levey, MBA2,3,
- for the HDClarity Investigators,
- Cristina Sampaio, MD2 and
- Edward J Wild, FRCP1,*
- 1UCL Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, London, UK
- 2CHDI Management/CHDI Foundation, Princeton, NJ, USA
- 3Enroll-HD platform, European Huntington’s Disease Network, University Hospital of Ulm, Ulm, Germany
- 4Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
- 5Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada
- 6Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 7Department of Neurology, Ulm University, Ulm, German
- ↵*Corresponding author:
Edward J Wild, UCL Huntington’s Disease Centre, 10-12 Russell Square House, London WC1B 5EH, UK, email: e.wild{at}ucl.ac.uk
Posted July 31, 2021.
Safety and feasibility of research lumbar puncture in Huntington’s disease: the HDClarity cohort and bioresource
